Shandong Weigao Group Medical Polymer Company Limited
SHWGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $13 | $13 | $14 | $13 |
| % Growth | -1.1% | -2.9% | 3.6% | – |
| Cost of Goods Sold | $7 | $7 | $7 | $6 |
| Gross Profit | $7 | $7 | $7 | $7 |
| % Margin | 50.3% | 50.2% | 53.6% | 55.9% |
| R&D Expenses | $1 | $1 | $1 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $4 | $4 | $4 | $4 |
| Sales & Mktg Exp. | $2 | $3 | $3 | $3 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | $4 | $4 | $4 | $4 |
| Operating Income | $2 | $2 | $3 | $3 |
| % Margin | 18.2% | 17.4% | 21.5% | 22% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | $3 | $2 | $3 | $3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $2 | $2 | $3 | $2 |
| % Margin | 15.8% | 15.1% | 20.3% | 17.3% |
| EPS | 0.46 | 0.44 | 0.61 | 0.51 |
| % Growth | 4.5% | -27.9% | 19.6% | – |
| EPS Diluted | 0.45 | 0.44 | 0.61 | 0.5 |
| Weighted Avg Shares Out | 5 | 5 | 5 | 5 |
| Weighted Avg Shares Out Dil | 5 | 5 | 5 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $4 | $4 | $4 | $4 |
| % Margin | 28.8% | 26.9% | 32.2% | 28.6% |